Asia-Pacific Electroceuticals Market

Asia-Pacific Electroceuticals Market Size, Share & Trends Analysis Report by Product (Cardioverter Defibrillators and Cardiac Pacemaker, Deep Brain Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators, Cochlear Implants, and Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)), by End-User (Hospitals and Clinics and Homecare and Other), Forecast Period 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jan 2020 | Report Code: OMR2020250 | Category : Medical Devices | Delivery Format: /

Asia-Pacific electroceuticals market is estimated to grow at a CAGR of around 8% during the forecast period. Moreover, increasing incidences of several health disorders such as spinal cord injuries, epilepsy, and other disorders are contributing to the growth of the electroceuticals market in the Asia-Pacific region. As per the estimation of the WHO, the incidence of Epilepsy is considerably high in emerging economies such as China and India. According to Epilepsia, the Official Journal of the International League Against Epilepsy, out of the around 4 billion people living in the Asia-Pacific region, about 23 million people had epilepsy in 2017. A large number of patients having epilepsy is driving market growth in Asia-Pacific as electroceuticals can prove to be a better option for the treatment of the disease.

Along with it, the healthcare infrastructure in the Asia-Pacific region is improving significantly owing to growing healthcare expenditure by individual and government along with rising insurance penetration which is expected to contribute significantly to the electroceutical market in the Asia-Pacific region. The emerging economies of Asia-Pacific, especially China and India are significantly investing in the development of innovative therapies. Also, the presence of various major market players operating in the Asia-Pacific region is boosting the market growth. For instance, Sonova Hearing (Suzhou) Co., Ltd., Sonova Japan Co, Ltd., Hearing Retail Group Pty. Ltd., Sonova Australia Pty Ltd., Sonova (Shanghai) Company, Ltd., and Triton Hearing, Ltd. are the subsidiaries of Sonova group operating in Asia-Pacific region. 

The market is segmented on the basis of product and end-user. On the basis of product, the market is segmented into cardioverter defibrillators and cardiac pacemaker, deep brain stimulators (DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids, and cochlear implants, and others such as sacral nerve stimulators, and transcutaneous electrical nerve stimulators. By End-user segment, the market is segmented into hospitals & clinics and homecare and other. Few players operating in the Asia-Pacific electroceuticals market include Medtronic PLC, Abbott Laboratories Inc., Boston Scientific Corp., LivaNova PLC, Cochlear, Ltd., Sonova Holding AG, Nevro Corp., ElectroCore LLC, and BioElectronics Corp.

Research Methodology

The market study of the Asia-Pacific electroceuticals market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  1. Asia-Pacific Electroceuticals Market Research and Analysis by Product 
  2. Asia-Pacific Electroceuticals Market Research and Analysis by End-User

The Report Covers

  • Comprehensive research methodology of the Asia-Pacific electroceuticals market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific electroceuticals market.
  • Insights about market determinants which are stimulating the Asia-Pacific electroceuticals market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis 

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants 

4.1. Motivators

4.2. Restraints

4.3. Opportunities 

5. Market Segmentation

5.1. Asia-Pacific Electroceuticals Market by Product and its Application

5.1.1. Cardioverter Defibrillators and Cardiac Pacemaker

5.1.1.1. Arrhythmias

5.1.2. Deep Brain Stimulators

5.1.2.1. Parkinson’s Disease

5.1.2.2. Depression

5.1.3. Spinal Cord Stimulators

5.1.3.1. Failed Back Syndrome

5.1.3.2. Ischemia

5.1.4. Vagus Nerve Stimulators

5.1.4.1. Epilepsy

5.1.5. Cochlear Implants

5.1.5.1. Sensorineural Hearing Loss

5.1.6. Others (Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)

5.1.6.1. Urinary Incontinence

5.1.6.2. Treatment-Resistant Depression

5.2. Asia-Pacific Electroceuticals Market by End-User

5.2.1. Hospitals and Clinics

5.2.2. Homecare and Other 

6. Regional Analysis

6.1. China

6.2. Japan

6.3. India

6.4. Rest of Asia-Pacific

7. Company Profiles

7.1. Abbott Laboratories, Inc.

7.2. Advanced Bionics AG

7.3. Boston Scientific Corp.

7.4. Cochlear, Ltd.

7.5. Demant A/S

7.6. Edwards Lifesciences Corp.

7.7. Getinge AB

7.8. GlaxoSmithKline PLC

7.9. Medtronic PLC

7.10. Sonova Holding AG

1. ASIA-PACIFIC ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)

2. ASIA-PACIFIC ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION) 

3. ASIA-PACIFIC ELECTROCEUTICALS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

1. ASIA-PACIFIC ELECTROCEUTICALS MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)

2. ASIA-PACIFIC ELECTROCEUTICALS MARKET SHARE BY END-USER, 2018 VS 2025 (%)

3. ASIA-PACIFIC ELECTROCEUTICALS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. CHINA ELECTROCEUTICALS MARKET SIZE, 2018-2025 ($ MILLION)

5. INDIA ELECTROCEUTICALS MARKET SIZE, 2018-2025 ($ MILLION)

6. JAPAN ELECTROCEUTICALS MARKET SIZE, 2018-2025 ($ MILLION)

7. REST OF ASIA-PACIFIC ELECTROCEUTICALS MARKET SIZE, 2018-2025 ($ MILLION)